Aurobindo Pharma Limited has informed the Exchange regarding a press release dated August 05, 2023, titled "Eugia Pharma receives USFDA Approval for Vancomycin Hydrochloride forInjection USP, 1.25 g/vial and 1.5 g/vial, Single-Dose Vials".
Aurobindo Pharma Limited has informed the Exchange regarding a press release dated August 05, 2023, titled "Eugia Pharma receives USFDA Approval for Vancomycin Hydrochloride forInjection USP, 1.25 g/vial and 1.5 g/vial, Single-Dose Vials".